Cytori Therapeutics reported $14.64M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Baxter International BAX:US $ 9075M 2M
Cerus CERS:US $ 79.41M 5.21M
Cytori Therapeutics CYTX:US $ 14.64M 3.81M
Genocea Biosciences GNCA:US $ 12.38M 14.69M
Haemonetics HAE:US $ 749.42M 18.65M
Infinity Pharmaceuticals INFI:US $ 9.98M 11.59M
Merrimack Pharmaceuticals MACK:US $ 14.08M 112K
Mirati Therapeutics MRTX:US $ 1249.28M 147.76M
Northwest Biotherapeutics NWBO:US -120525000 3.47M
Starpharma Holdings Ltd SPL:AU 55.08M 7.22M
Teva Pharmaceutical TEVA:IT 9.34B 934M